ArticleAntibiotics (Basel, Switzerland)2026
Reduced Susceptibility to Cefiderocol Among Clinical MCR-1-Producing
Nadia Jaidane, Thierry Naas, Souad Fayad, Pierre Châtre, Wejdene Mansour, Aymen Bouaziz, Pauline François, Laetitia Du Fraysseix, Bogdan I Iorga, Nahed A Al Laham and 3 more
Abstract read
In one paragraphArticle in Antibiotics (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
13 authors.
Nadia JaidaneLaboratory of Metabolic Biophysics and Applied Pharmacology (LR12ES02), Department of Biophysics, Faculty of Medicine Ibn El Jazzar of Sousse, University of Sousse, Sousse 4002, Tunisia.ORCID 0000-0001-6141-423X Thierry NaasTeam 'Resist', UMR1184 'Infectious Disease Models and Innovative Therapies (IDMIT)' (INSERM, University Paris-Saclay, CEA), Faculty of Medicine, University Paris-Saclay, 94270 Le Kremlin-Bicêtre, France.ORCID 0000-0001-9937-9572 Souad FayadTeam 'Resist', UMR1184 'Infectious Disease Models and Innovative Therapies (IDMIT)' (INSERM, University Paris-Saclay, CEA), Faculty of Medicine, University Paris-Saclay, 94270 Le Kremlin-Bicêtre, France.ORCID 0009-0007-4539-9261 Pierre ChâtreUnité Antibiorésistance et Virulence Bactériennes, ANSES-Université de Lyon, 69007 Lyon, France.ORCID 0000-0003-4294-2824 Wejdene MansourLaboratory of Metabolic Biophysics and Applied Pharmacology (LR12ES02), Department of Biophysics, Faculty of Medicine Ibn El Jazzar of Sousse, University of Sousse, Sousse 4002, Tunisia.
Aymen BouazizLaboratory of Bacteriology, Military Hospital of Tunis, Tunis 1008, Tunisia.
Pauline FrançoisUnité Antibiorésistance et Virulence Bactériennes, ANSES-Université de Lyon, 69007 Lyon, France.ORCID 0009-0007-7423-3594 Laetitia Du FraysseixUnité Antibiorésistance et Virulence Bactériennes, ANSES-Université de Lyon, 69007 Lyon, France.
Bogdan I IorgaInstitut de Chimie des Substances Naturelles, CNRS, Université Paris-Saclay, 91190 Gif-sur-Yvette, France.
Nahed A Al LahamTeam 'Resist', UMR1184 'Infectious Disease Models and Innovative Therapies (IDMIT)' (INSERM, University Paris-Saclay, CEA), Faculty of Medicine, University Paris-Saclay, 94270 Le Kremlin-Bicêtre, France.ORCID 0000-0002-7019-7975 Lamia TiloucheLaboratory of Metabolic Biophysics and Applied Pharmacology (LR12ES02), Department of Biophysics, Faculty of Medicine Ibn El Jazzar of Sousse, University of Sousse, Sousse 4002, Tunisia.
Marisa HaenniUnité Antibiorésistance et Virulence Bactériennes, ANSES-Université de Lyon, 69007 Lyon, France.ORCID 0000-0003-1333-5603 Funding
Assistance Publique - Hôpitaux de ParisERA-NET JPIAMR-ACTION ENVIREFrench Agency for Food, Environmental and Occupational Health & SafetyFrench Embassy in Lebanon SAFAR fellowshipInserm UMR1184International Centre for Antimicrobial Resistance Solutions 200005National Agency for Research ANR-20-PAMR-0010Université Paris-Saclay U1184
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
cefiderocol resistanceCirAcolistin resistanceEscherichia coliFiuIncI2IncX4mcr-1.1plasmid-mediated resistanceTonBTunisia
Identifiers
PMID42650727
PMCPMC13509618
What OpenQuestion holds
Textmetadata
Read underepoch 390